On May 1st, Clinical Leader announced the 2024 Leadership Awards, supported by data from ISR Reports. The CRO Leadership Awards recognize Phase 1 and Phase 2/3 CROs for comprehensive excellence across their capabilities, compatibility, expertise, quality, and reliability. 2024 marks the 11th consecutive year that Worldwide has been rated as a high-performing CRO based on primary market research. The 2024 data show that Worldwide outperformed other Phase 2/3 CROs for Project Manager Quality and Worldwide achieved top marks across all five categories and was honored as a “Champion” in several categories across Big Pharma.
Want to learn more about Worldwide Clinical Trials?
Worldwide Clinical welcomes you to our site. We collect information about your browsing experience such as cookies, pixels, and web beacons (collectively, “cookies”) to assist with improving your experience with our website. You may ‘Agree’ to accept categories of cookies or ‘Decline’ to reject optional cookies, or otherwise manage your preferences by clicking on the button, ‘Manage Cookie Options‘ below. Worldwide uses Essential Cookies, thus you may not opt of these Cookies as they are deployed to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For additional information on the categories of data we collect, the purposes for their collection, disclosures to third parties, and data retention, please visit our Privacy Policy or Cookie Notice for more information.
